Vanguard Capital Management Acquires 5.09% Stake in Novavax Inc (NVAX)

On April 30, 2026, Vanguard Capital Management LLC filed a Schedule 13G with the SEC, reporting a significant new ownership stake in Novavax Inc (NVAX). As of the event date on March 31, 2026, Vanguard reported beneficial ownership of 8,305,681 shares of common stock, representing 5.09% of the company. This filing marks an increase from a previously reported 0% stake. According to the filing, Vanguard Capital Management exercises sole dispositive power over all 8,305,681 shares, while holding sole voting power over 1,175,534 shares. The filing includes holdings managed by several affiliates, including Vanguard Asset Management Limited and Vanguard Global Advisers, LLC. The shares were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of Novavax Inc. No other single person's interest in these securities exceeds 5%. The reporting person is classified as an Investment Adviser under Rule 13d-1(b).